• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma


1,390.85 INR 1.95 0.14%

As of 11:00:28 ET on 10/23/2014.

Snapshot for Lupin Ltd (LPC)

Open: 1,397.95 Day's Range: 1,385.00 - 1,400.00 Volume: 67,866
Previous Close: 1,388.90 52wk Range: 840.40 - 1,442.30 1-Yr Rtn: +57.32%

Stock Chart for LPC

No chart data available.
  • LPC:IN 1,388.30
  • 1D
  • 1M
  • 1Y
Interactive LPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LPC

Current P/E Ratio (ttm) 33.9314
Estimated P/E(03/2015) 26.8665
Relative P/E vs. SENSEX 1.8303
Earnings Per Share (INR) (ttm) 40.9900
Est. EPS (INR) (03/2015) 51.7690
Est. PEG Ratio 1.0968
Market Cap (M INR) 624,549.51
Shares Outstanding (M) 449.04
30 Day Average Volume 545,535
Price/Book (mrq) 8.9969
Price/Sale (ttm) 5.5205
Dividend Indicated Gross Yield 0.22%
Cash Dividend (INR) 3.0000
Dividend Ex-Date 07/21/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LPC

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for LPC

Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

Desh Bandhu GuptaChairman/FounderKamal Kishore SharmaVice Chairman
Vinita GuptaChief Executive OfficerNilesh D GuptaManaging Director
More Company Profile & Key Executives for LPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil